Patent · US Active

Method of differentiating human pluripotent cells into cardiac fibroblasts

US11072780B2 · kind B2 · utility

0Cited by

3References

8Claims

0Family size

Assignee

Wisconsin Alumni Research Foundation · US

Inventors

Timothy Kamp · Cincinnati, US
Jianhua Zhang · Tangxia, CN

Key dates

Filing date	Sep 29, 2017
Grant date	Jul 27, 2021
Priority date	—
Expiry date	Sep 29, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2533/90
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Methods for generating high-yield, high-purity cardiac fibroblasts are described. Differentiation methods comprising chemically defined culture conditions and methods for in vitro maintenance of human pluripotent stem cell-derived cardiac fibroblasts are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.